Zevra Therapeutics Inc — Cash Flow (NASDAQ:ZVRA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -1.94 M10.44 M-18.72 M-33.53 M-69.67 M-1.6 M -1.6 M Cash from investing activities -33 K-15.52 M-36.72 M-17.39 M-22.16 M18.13 M 18.13 M Cash from financing activities 2.74 M113.11 M8.35 M28.46 M82.11 M12.06 M 12.06 M Free cash flow -1.97 M10.34 M-18.81 M-33.83 M-75.67 M-2.43 M -2.43 M

News

BTIG initiates Zevra Therapeutics stock with buy on Miplyffa outlook

Micron and BioNTech among market cap stock movers on Tuesday

Micron and Palantir among market cap stock movers on Tuesday

ExxonMobil, Chevron edge lower premarket; Hewlett Packard Enterprise climbs

Guggenheim raises Zevra Therapeutics stock price target to $23

Earnings call transcript: Zevra Therapeutics Q4 2025 earnings beat forecasts

Zevra Therapeutics, Inc. (ZVRA) Q4 2025 Earnings Call Transcript

Zevra Therapeutics earnings beat by $0.14, revenue topped estimates

Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue Estimates

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates

Neil F. McFarlane, Zevra Therapeutics president, sells $125k in shares